137 related articles for article (PubMed ID: 27178118)
21. Focal myocardial perfusion abnormalities in cardiac amyloidosis as compared with CMR, bone scintigraphy, and
Ensako T; Norikane T; Yamamoto Y; Takami Y; Mitamura K; Maeda Y; Noma T; Nishiyama Y
J Nucl Cardiol; 2021 Oct; 28(5):2408-2411. PubMed ID: 32909242
[No Abstract] [Full Text] [Related]
22. Significance of
Minamimoto R; Awaya T; Iwama K; Hotta M; Nakajima K; Hirai R; Okazaki O; Hiroi Y
J Nucl Cardiol; 2020 Feb; 27(1):202-209. PubMed ID: 29589208
[TBL] [Abstract][Full Text] [Related]
23. Amyloid PET imaging in cardiac amyloidosis: a pilot study using
Dietemann S; Nkoulou R
Ann Nucl Med; 2019 Aug; 33(8):624-628. PubMed ID: 31140154
[TBL] [Abstract][Full Text] [Related]
24. Novel imaging techniques using
Shouman K; Broski SM; Muchtar E; Pendleton CA; Johnson GB; Tracy J; Engelstad JK; Spinner RJ; Dyck PJB
Muscle Nerve; 2021 Jan; 63(1):104-108. PubMed ID: 33094511
[TBL] [Abstract][Full Text] [Related]
25. 18F-florbetapir PET in patients with frontotemporal dementia and Alzheimer disease.
Kobylecki C; Langheinrich T; Hinz R; Vardy ER; Brown G; Martino ME; Haense C; Richardson AM; Gerhard A; Anton-Rodriguez JM; Snowden JS; Neary D; Pontecorvo MJ; Herholz K
J Nucl Med; 2015 Mar; 56(3):386-91. PubMed ID: 25655625
[TBL] [Abstract][Full Text] [Related]
26. A Semiautomated Method for Quantification of F 18 Florbetapir PET Images.
Joshi AD; Pontecorvo MJ; Lu M; Skovronsky DM; Mintun MA; Devous MD
J Nucl Med; 2015 Nov; 56(11):1736-41. PubMed ID: 26338898
[TBL] [Abstract][Full Text] [Related]
27. 18F-Florbetaben: A New Tool for Amyloidosis Staging?
D'Estanque E; Chambert B; Moranne O; Kotzki PO; Boudousq V
Clin Nucl Med; 2017 Jan; 42(1):50-53. PubMed ID: 27801739
[TBL] [Abstract][Full Text] [Related]
28. Clinical Utility of 18F-Florbetaben PET for Detecting Amyloidosis Associated With Multiple Myeloma: A Prospective Case-Control Study.
Seo M; Cha HJ; Kim M; Park SH; Lim JH; Choi Y; Lee YJ; Park SH; Jo JC
Clin Nucl Med; 2019 Sep; 44(9):e503-e509. PubMed ID: 31283608
[TBL] [Abstract][Full Text] [Related]
29. A sparkling case of familial, cardiac-specific amyloidosis.
Villines TC; Atwood JE
Clin Cardiol; 2006 Feb; 29(2):89. PubMed ID: 16506646
[No Abstract] [Full Text] [Related]
30. Potential utility of
Tani Y; Norikane T; Takami Y; Mitamura K; Yamamoto Y; Morimoto M; Noma T; Nishiyama Y
J Nucl Cardiol; 2022 Dec; 29(6):3557-3561. PubMed ID: 33748936
[No Abstract] [Full Text] [Related]
31. Cardiac Amyloid Imaging with 18F-Florbetaben PET: A Pilot Study.
Law WP; Wang WY; Moore PT; Mollee PN; Ng AC
J Nucl Med; 2016 Nov; 57(11):1733-1739. PubMed ID: 27307344
[TBL] [Abstract][Full Text] [Related]
32. 18F-Florbetapir Binds Specifically to Myocardial Light Chain and Transthyretin Amyloid Deposits: Autoradiography Study.
Park MA; Padera RF; Belanger A; Dubey S; Hwang DH; Veeranna V; Falk RH; Di Carli MF; Dorbala S
Circ Cardiovasc Imaging; 2015 Aug; 8(8):. PubMed ID: 26259579
[TBL] [Abstract][Full Text] [Related]
33. Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease.
Fleisher AS; Chen K; Liu X; Roontiva A; Thiyyagura P; Ayutyanont N; Joshi AD; Clark CM; Mintun MA; Pontecorvo MJ; Doraiswamy PM; Johnson KA; Skovronsky DM; Reiman EM
Arch Neurol; 2011 Nov; 68(11):1404-11. PubMed ID: 21747008
[TBL] [Abstract][Full Text] [Related]
34. Reproducibility and repeatability of assessment of myocardial light chain amyloidosis burden using
Prato FS; Wisenberg G
J Nucl Cardiol; 2021 Oct; 28(5):2011-2013. PubMed ID: 31797317
[No Abstract] [Full Text] [Related]
35. Causes and Consequences of Longitudinal LV Dysfunction Assessed by 2D Strain Echocardiography in Cardiac Amyloidosis.
Ternacle J; Bodez D; Guellich A; Audureau E; Rappeneau S; Lim P; Radu C; Guendouz S; Couetil JP; Benhaiem N; Hittinger L; Dubois-Randé JL; Plante-Bordeneuve V; Mohty D; Deux JF; Damy T
JACC Cardiovasc Imaging; 2016 Feb; 9(2):126-38. PubMed ID: 26777222
[TBL] [Abstract][Full Text] [Related]
36. The diagnostic performance of cardiac magnetic resonance in detection of myocardial involvement in AL amyloidosis.
Fikrle M; Palecek T; Masek M; Kuchynka P; Straub J; Spicka I; Rysava R; Linhart A
Clin Physiol Funct Imaging; 2016 May; 36(3):218-24. PubMed ID: 25393773
[TBL] [Abstract][Full Text] [Related]
37. Is 18F-flutemetamol PET/CT able to reveal cardiac amyloidosis?
Lhommel R; Sempoux C; Ivanoiu A; Michaux L; Gerber B
Clin Nucl Med; 2014 Aug; 39(8):747-9. PubMed ID: 24978329
[TBL] [Abstract][Full Text] [Related]
38. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y
Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833
[TBL] [Abstract][Full Text] [Related]
39. Imaging an ATTR cardiac amyloidosis patient using fluorine-18 sodium fluoride PET/CT: A case report.
Mayurasakorn S; Kiatkittikul P; Chotipanich C; Promteangtrong C; Kunawudhi A; Siripongsatian D; Iamsa-Art C
J Nucl Cardiol; 2022 Dec; 29(6):3554-3556. PubMed ID: 33723768
[No Abstract] [Full Text] [Related]
40. GMP-compliant automated synthesis of [(18)F]AV-45 (Florbetapir F 18) for imaging beta-amyloid plaques in human brain.
Yao CH; Lin KJ; Weng CC; Hsiao IT; Ting YS; Yen TC; Jan TR; Skovronsky D; Kung MP; Wey SP
Appl Radiat Isot; 2010 Dec; 68(12):2293-7. PubMed ID: 20638295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
